[FG] Khanna Gremmelmeier Nina

Frank, F.A. et al. (2025) ‘Current Concepts in Shoulder Periprosthetic Joint Infections—Are Shoulders the Same as Hips and Knees?’, Journal of Clinical Medicine, 14(8), p. 2578. Available at: https://doi.org/10.3390/jcm14082578.

van Delden, C. et al. (2025) ‘The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research’, Transplant Infectious Disease [Preprint]. Available at: https://doi.org/10.1111/tid.70023.

Nyffeler, Ramon et al. (2025) ‘Fracture-related infections of the lower extremity – Analysis of costs and their drivers’, Injury, 56(2), p. 112138. Available at: https://doi.org/10.1016/j.injury.2024.112138.

van den Berg, Jana et al. (2025) ‘Basic Concepts and Indications of CAR T Cells’, Hamostaseologie, 45, pp. 14–23. Available at: https://doi.org/10.1055/a-2491-3652.

Kinoshita, Hannah et al. (2025) ‘T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy’, Transplantation and Cellular Therapy [Preprint]. Available at: https://doi.org/10.1016/j.jtct.2025.02.019.

Kusejko, Katharina et al. (2024) ‘Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study’, BMC Infectious Diseases, 24(1). Available at: https://doi.org/10.1186/s12879-024-10026-7.

Maffei, Enea et al. (2024) ‘Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication’, Nature Communications, 15(1). Available at: https://doi.org/10.1038/s41467-023-44157-3.

Rentsch, Katharina M. et al. (2024) ‘Enhancing Stability and Investigating Target Attainment of Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Insights from In Vitro and In Vivo Evaluations’, Antibiotics, 13(10), p. 970. Available at: https://doi.org/10.3390/antibiotics13100970.

Palianina, D. et al. (2024) ‘Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo’, Science advances, 10(34). Available at: https://doi.org/10.1126/sciadv.ado2048.

Hofer, Kevin D. et al. (2024) ‘B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma’, British Journal of Haematology, 205(2), pp. 722–725. Available at: https://doi.org/10.1111/bjh.19571.

Neofytos, D. and Khanna, N. (2024) ‘How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients’, Transplant Infectious Disease, 26(4). Available at: https://doi.org/10.1111/tid.14332.

Forrer, Pascal et al. (2024) ‘Unveiling signaling pathways inducing MHC class II expression in neutrophils’, Frontiers in Immunology, 15. Available at: https://doi.org/10.3389/fimmu.2024.1444558.

De Greef, Julien et al. (2024) ‘Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Journal of Infection, 88(6). Available at: https://doi.org/10.1016/j.jinf.2024.106162.

Portillo, V. et al. (2024) ‘Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update’, Open Forum Infectious Diseases, 11(5). Available at: https://doi.org/10.1093/ofid/ofae201.

Salmanton-García, Jon et al. (2024) ‘Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022’, eClinicalMedicine, 71. Available at: https://doi.org/10.1016/j.eclinm.2024.102553.

Hosseini-Moghaddam, Seyed M. et al. (2024) ‘Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020’, American Journal of Transplantation, 24(4), pp. 653–668. Available at: https://doi.org/10.1016/j.ajt.2023.11.003.

Ragozzino, Silvio et al. (2024) ‘Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study’, Bone Marrow Transplantation, 59(2), pp. 278–281. Available at: https://doi.org/10.1038/s41409-023-02157-3.

Søgaard, Kirstine K. et al. (2024) ‘Evaluation of the clinical relevance of the Biofire© FilmArray pneumonia panel among hospitalized patients’, Infection, 52(1), pp. 173–181. Available at: https://doi.org/10.1007/s15010-023-02080-1.

Sollier, Julie et al. (2024) ‘Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditions’, Nature Microbiology, 9(1), pp. 1–3. Available at: https://doi.org/10.1038/s41564-023-01566-w.

Agnetti, Jessica et al. (2023) ‘Identification of microorganisms by a rapid PCR panel from positive blood cultures leads to faster optimal antimicrobial therapy – a before-after study’, BMC Infectious Diseases, 23(1). Available at: https://doi.org/10.1186/s12879-023-08732-9.

Arendrup, M.C. et al. (2023) ‘European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study’, Journal of Infection, 87(5), pp. 428–437. Available at: https://doi.org/10.1016/j.jinf.2023.08.001.

Palianina, D. et al. (2023) ‘A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications’, Molecular Therapy Methods and Clinical Development, 30, pp. 147–160. Available at: https://doi.org/10.1016/j.omtm.2023.06.007.

Hoenigl M et al. (2023) ‘Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study’, The Lancet Infectious Diseases, 23(6), pp. 751–761. Available at: https://doi.org/10.1016/S1473-3099(22)00872-6.

Neofytos D et al. (2023) ‘Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update’, Open Forum Infectious Diseases, 10(6), p. ofad247. Available at: https://doi.org/10.1093/ofid/ofad247.

Walti, Laura N. et al. (2023) ‘Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland’, JAMA Network Open, 6(4), p. E2310687. Available at: https://doi.org/10.1001/jamanetworkopen.2023.10687.

Schaeffer Thibault et al. (2023) ‘Long-Term Follow-Up after Mycobacterium Chimaera Infection Following Cardiac Surgery: Single-Center Experience’, Journal of Clinical Medicine, 12(3). Available at: https://doi.org/10.3390/jcm12030948.

Busca A et al. (2023) ‘Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry’, Frontiers in Immunology, 14, p. 1125030. Available at: https://doi.org/10.3389/fimmu.2023.1125030.

Criscuolo M et al. (2023) ‘SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report’, Journal of Investigational Allergology and Clinical Immunology, 33(3), pp. 225–227. Available at: https://doi.org/10.18176/jiaci.0845.

Marchesi F et al. (2023) ‘COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)’, Haematologica, 108(1), pp. 22–33. Available at: https://doi.org/10.3324/haematol.2022.280847.

Sava M et al. (2023) ‘Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates’, Bone Marrow Transplantation, 58(1). Available at: https://doi.org/10.1038/s41409-022-01851-y.

Castellanos-Rueda R et al. (2022) ‘speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing’, Nature Communications, 13(1), p. 6555. Available at: https://doi.org/10.1038/s41467-022-34141-8.

Gürtler N et al. (2022) ‘Nosocomial human parainfluenza virus type 3 outbreak in immunocompromised patients, and possible lessons from the SARS-CoV-2 pandemic’, Journal of Hospital Infection, 129. Available at: https://doi.org/10.1016/j.jhin.2022.07.002.

Palianina, D. et al. (2022) A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell therapy applications. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.10.31.514542.

Blaskovich Mark A.T. et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662). Available at: https://doi.org/10.1126/scitranslmed.abj238.

Blaskovich MAT et al. (2022) ‘A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections’, Science Translational Medicine, 14(662), p. eabj2381. Available at: https://doi.org/10.1126/scitranslmed.abj238.

Darie, Andrei M et al. (2022) ‘Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial’, The Lancet Respiratory Medicine, 10(9), pp. 877–887. Available at: https://doi.org/10.1016/S2213-2600(22)00086-8.

Averbuch D et al. (2022) ‘Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation’, Clinical Infectious Diseases, 75(1), pp. 88–97. Available at: https://doi.org/10.1093/cid/ciab866.

van den Bogaart L et al. (2022) ‘Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study’, Journal of Infection, 85(1), pp. 1–7. Available at: https://doi.org/10.1016/j.jinf.2022.05.019.

Busca A et al. (2022) ‘COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP’, Blood Advances, 6(7), pp. 2427–2433. Available at: https://doi.org/10.1182/bloodadvances.2021005616.

Cardoso E et al. (2022) ‘Is sleep disordered breathing a risk factor for COVID-19 or vice versa?’, ERJ Open Research, 8(2). Available at: https://doi.org/10.1183/23120541.00034-2022.

Ragozzino S et al. (2022) ‘Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples from Swiss Tertiary Care Hospitals’, Open Forum Infectious Diseases, 9(2), p. ofab638. Available at: https://doi.org/10.1093/ofid/ofab638.

Carere-Sigl, Anja et al. (2022) ‘FimH antagonists prevent biofilm formation on catheter surfaces’, Carbohydrate Chemistry, 45, pp. 519–536. Available at: https://doi.org/10.1039/9781839164538-00519.

Jahn K et al. (2022) ‘Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning’, 59(1). Available at: https://doi.org/10.1183/13993003.01136-2021.

Axfors C et al. (2021) ‘Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials’, BMC Infectious Diseases, 21(1), p. 1170. Available at: https://doi.org/10.1186/s12879-021-06829-7.

Leuzinger K et al. (2021) ‘Comparing immunoassays for sars-cov-2 antibody detection in patients with and without laboratory-confirmed sars-cov-2 infection’, Journal of Clinical Microbiology, 59(12), p. e0138121. Available at: https://doi.org/10.1128/JCM.01381-21.

Pagano, Livio et al. (2021) ‘COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)’, Journal of Hematology and Oncology, 14(1). Available at: https://doi.org/10.1186/s13045-021-01177-0.

Rüeger, Sina et al. (2021) ‘The influence of human genetic variation on Epstein–Barr virus sequence diversity’, Scientific Reports, 11(1). Available at: https://doi.org/10.1038/s41598-021-84070-7.

Rüeger, Sina et al. (2021) ‘Author Correction: The influence of human genetic variation on Epstein–Barr virus sequence diversity (Scientific Reports, (2021), 11, 1, (4586), 10.1038/s41598-021-84070-7)’, Scientific Reports, 11(1). Available at: https://doi.org/10.1038/s41598-021-87274-z.

Søgaard KK et al. (2021) ‘Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia’, Journal of Intensive Care, 9(1), p. 10. Available at: https://doi.org/10.1186/s40560-021-00526-y.

Gutiérrez-Gutiérrez, B. et al. (2021) ‘Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients’, Antimicrobial Agents and Chemotherapy, 65(11). Available at: https://doi.org/10.1128/AAC.01102-21.

Adam KM et al. (2021) ‘Trends of the epidemiology of Candidemia in Switzerland: A 15-year FUNGINOS survey’, Open Forum Infectious Diseases, 8(10), p. ofab471. Available at: https://doi.org/10.1093/ofid/ofab471.

Zweifel SA et al. (2021) ‘Long-term clinical and multimodal imaging findings in patients with disseminated mycobacterium chimaera infection’, Journal of Clinical Medicine, 10(18). Available at: https://doi.org/10.3390/jcm10184178.

Di Roberto, R.B. et al. (2021) speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2021.08.23.457342.

Sava M et al. (2021) ‘Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study’, Swiss Medical Weekly, 151(31), p. w20550. Available at: https://doi.org/10.4414/smw.2021.20550.

Sedlmayer F et al. (2021) ‘5-Fluorouracil blocks quorum-sensing of biofilm-embedded methicillin-resistant Staphylococcus aureus in mice’, Nucleic Acids Research, 49(13), p. e73. Available at: https://doi.org/10.1093/nar/gkab251.

Diebold M et al. (2021) ‘Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study’, Swiss Medical Weekly, 151(29-30), p. w20572. Available at: https://doi.org/10.4414/smw.2021.20572.

Kraljevic M et al. (2021) ‘Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients’, Medical Mycology, 59(7), pp. 701–711. Available at: https://doi.org/10.1093/mmy/myaa106.

Walti LN et al. (2021) ‘Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study’, American Journal of Transplantation, 21(7), pp. 2532–2542. Available at: https://doi.org/10.1111/ajt.16423.

Hinić V et al. (2021) ‘Unexpected Mycoplasma hominis infection in two renal transplant recipients traced back to the same donor by whole-genome sequencing’, European Journal of Clinical Microbiology and Infectious Diseases, 40(5), pp. 1097–1102. Available at: https://doi.org/10.1007/s10096-020-04116-y.

Glampedakis E et al. (2021) ‘Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study’, Clinical Infectious Diseases, 72(8), pp. 1379–1385. Available at: https://doi.org/10.1093/cid/ciaa230.

Leuzinger K et al. (2021) ‘Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures’, Journal of Medical Virology, 93(4), pp. 2374–2384. Available at: https://doi.org/10.1002/jmv.26731.

Janiaud P et al. (2021) ‘Association of Convalescent Plasma Treatment with Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis’, JAMA - Journal of the American Medical Association, 325(12), pp. 1185–1195. Available at: https://doi.org/10.1001/jama.2021.2747.

Leuzinger K et al. (2021) ‘Corrigendum to: Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.’, The Journal of infectious diseases, 223(4), pp. 734–735. Available at: https://doi.org/10.1093/infdis/jiaa667.

Cesaro, S., Ragozzino, S. and Khanna, N. (2021) ‘Polyomavirus, Adenovirus, and Viral Respiratory Diseases’. Springer Science and Business Media Deutschland GmbHinfo@springer-sbm.com, pp. 191–219. Available at: https://doi.org/10.1007/978-3-030-57317-1_14.

Durovic A et al. (2021) ‘Two simultaneous cases of disseminated infections with Campylobacter fetus: clinical characteristics and molecular comparison’, 27(1). Available at: https://doi.org/10.1016/j.cmi.2020.07.018.

Kusejko K et al. (2020) ‘Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV’, PLoS Biology, 18(12), p. e3000963. Available at: https://doi.org/10.1371/journal.pbio.3000963.

Leuzinger K et al. (2020) ‘Epidemiology of severe acute respiratory syndrome Coronavirus 2 emergence amidst community-acquired respiratory viruses’, Journal of Infectious Diseases, 222(8), pp. 1270–1279. Available at: https://doi.org/10.1093/infdis/jiaa464.

Coste AT et al. (2020) ‘Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland’, Infection, 48(5), pp. 761–766. Available at: https://doi.org/10.1007/s15010-020-01475-8.

Studer U et al. (2020) ‘Incidence of CMV replication and the role of letermovir primary/secondary prophylaxis in the early phase after allogeneic hematopoietic stem cell transplantation ⇓ a single centre study’, Anticancer Research, 40(10), pp. 5909–5917. Available at: https://doi.org/10.21873/anticanres.14611.

Tschopp, Jonathan et al. (2020) ‘First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study’, American Journal of Transplantation, 20, pp. 2876–2882. Available at: https://doi.org/10.1111/ajt.16062.

van Delden C et al. (2020) ‘Burden and timeline of infectious diseases in the first year after solid organ transplantation in the swiss transplant cohort study’, Clinical Infectious Diseases, 71(7), pp. E159–E169. Available at: https://doi.org/10.1093/cid/ciz1113.

Olearo F. et al. (2020) ‘Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients’, Open Forum Infectious Diseases, 7(7), p. ofaa246. Available at: https://doi.org/10.1093/ofid/ofaa246.

Erba A et al. (2020) ‘OPAT in Switzerland: single-center experience of a model to treat complicated infections’, Infection, 48(2), pp. 231–240. Available at: https://doi.org/10.1007/s15010-019-01381-8.

Poissy, J. et al. (2020) ‘Risk factors for candidemia: A prospective matched case-control study’, Critical Care, 24(1). Available at: https://doi.org/10.1186/s13054-020-2766-1.

Stemler J. et al. (2020) ‘Baseline chest computed tomography as standard of care in high‐risk hematology patients’, Journal of Fungi, 6(1). Available at: https://doi.org/10.3390/jof6010036.

Passweg JR, Khanna, Nina and Halter, Joerg (2020) ‘Respiratory viral infections prior to and after allogeneic haematopoietic cell transplantation’, 188(4). Available at: https://doi.org/10.1111/bjh.16215.

Boeddinghaus, Jasper et al. (2020) ‘Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland’, International journal of cardiology, 32, p. 100686. Available at: https://doi.org/10.1016/j.ijcha.2020.100686.

Marzolini, Catia et al. (2020) ‘Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations’, Antimicrobial Agents and Chemotherapy, 64(9), pp. e01177–20. Available at: https://doi.org/10.1128/aac.01177-20.

Von Rotz M. et al. (2020) ‘A holiday souvenir with consequences - An interdisciplinary challenge Folgenreiches Feriensouvenir - Eine interdisziplinäre Herausforderung’, Praxis, 109(2), pp. 109–115. Available at: https://doi.org/10.1024/1661-8157/a003381.

Weisshaar, Kimmo et al. (2020) ‘Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH)’, Orphanet journal of rare diseases : OJRD, 15(1), p. 249. Available at: https://doi.org/10.1186/s13023-020-01532-3.

Zingg, Sandra et al. (2020) ‘Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature’, Open Forum Infectious Diseases, 7(6), p. ofaa185. Available at: https://doi.org/10.1093/ofid/ofaa185.

Osthoff ,Michael, Bättig,Veronika and Khanna,Nina (2019) ‘USE OF ISAVUCONAZOL FOR INVASIVE FUNGICAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE AND ALLOGEN TRANSPLANTATION: INITIAL EXPERIENCE IN A SINGLE CENTER’. FERRATA STORTI FOUNDATION, 104.

Fischer, A. et al. (2019) RpiRc regulates RsbU to modulate eDNA-dependent biofilm formation and<i>in vivo</i>virulence of<i>Staphylococcus aureus</i>in a mouse model of catheter infection. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/783985.

Wüthrich D et al. (2019) ‘Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline’, 74(5). Available at: https://doi.org/10.1093/jac/dkz003.

Moriarty TF et al. (2019) ‘Recommendations for design and conduct of preclinical in vivo studies of orthopedic device-related infection’, Journal of Orthopaedic Research, 37(2), pp. 271–287. Available at: https://doi.org/10.1002/jor.24230.

Jayachandran, Rajesh et al. (2019) ‘Disruption of Coronin 1 Signaling in T Cells Promotes Allograft Tolerance while Maintaining Anti-Pathogen Immunity’, Immunity, 50(1), pp. 152–165.e8. Available at: https://doi.org/10.1016/j.immuni.2018.12.011.

Kritikos A et al. (2018) ‘Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS)’, Clinical Microbiology and Infection. 15.06.2018, 24(11), p. 1214.e1–1214.e4. Available at: https://doi.org/10.1016/j.cmi.2018.05.012.

Woischnig, Anne-Kathrin et al. (2018) ‘Acrylic microparticles increase daptomycin intracellular and in vivo anti-biofilm activity against Staphylococcus aureus’, International Journal of Pharmaceutics. 25.08.2018, 550(1-2), pp. 372–379. Available at: https://doi.org/10.1016/j.ijpharm.2018.08.048.

Wehrle-Wieland E et al. (2018) ‘Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL’, Transplant Infectious Disease, 20(5), p. e12953. Available at: https://doi.org/10.1111/tid.12953.

Robert-Gangneux F. et al. (2018) ‘Toxoplasmosis in transplant recipients, Europe, 2010–2014’, Emerging Infectious Diseases, 24(8), pp. 1497–1504. Available at: https://doi.org/10.3201/eid2408.180045.

Liu, Ying et al. (2018) ‘Immunomimetic Designer Cells Protect Mice from MRSA Infection’, Cell. 21.06.2018, 174(2), pp. 259–270.e11. Available at: https://doi.org/10.1016/j.cell.2018.05.039.

Naegele K et al. (2018) ‘Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results’, Journal of Clinical Virology, 104, pp. 39–47. Available at: https://doi.org/10.1016/j.jcv.2018.04.013.

Orasch C et al. (2018) ‘Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study’, Journal of Infection. 31.01.2018, 76(5), pp. 489–495. Available at: https://doi.org/10.1016/j.jinf.2017.12.018.

Spahr, Yasmin et al. (2018) ‘Community-acquired respiratory paramyxovirus infection after allogeneic hematopoietic cell transplantation: A single-center experience’, Open Forum Infectious Diseases. 12.04.2018, 5(5), p. ofy077. Available at: https://doi.org/10.1093/ofid/ofy077.

Kurioka A. et al. (2018) ‘CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells’, Frontiers in Immunology, 9(APR). Available at: https://doi.org/10.3389/fimmu.2018.00486.

Damonti, Lauro et al. (2018) ‘Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia (Intensive Care Medicine, (2017), 43, 6, (935-939), 10.1007/s00134-017-4737-9)’, Intensive Care Medicine, 44(3), pp. 405–407. Available at: https://doi.org/10.1007/s00134-018-5081-4.

Cremonesi, Eleonora et al. (2018) ‘Gut microbiota modulate T cell trafficking into human colorectal cancer’, Gut, 67, pp. 1984–1994. Available at: https://doi.org/10.1136/gutjnl-2016-313498.

Kuster, Sabine et al. (2018) ‘Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study’, Transplant infectious disease : an official journal of the Transplantation Society, 20(6), p. e12981. Available at: https://doi.org/10.1111/tid.12981.

Nguyen, Minh-Thu et al. (2017) ‘Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responses’, Nature Communications. 21.12.2017, 8(1), p. 2246. Available at: https://doi.org/10.1038/s41467-017-02234-4.

Lebeaux D. et al. (2017) ‘Outcome and Treatment of Nocardiosis after Solid Organ Transplantation: New Insights from a European Study’, Clinical Infectious Diseases, 64(10), pp. 1396–1405. Available at: https://doi.org/10.1093/cid/cix124.